文献速递心脑血管急症重症综合管理与镇静镇痛

神经重症监护病房中使用血管活性药物患者的无创血压与有创动脉血压的相关性

Correlation of Noninvasive Blood Pressure and Invasive Intra-arterial Blood Pressure in Patients Treated with Vasoactive Medications in a Neurocritical Care Unit.
PubMed 文献 · Neurocrit Care · 2018-01-01
一句话结论在神经重症监护病房使用血管活性药物时,无创血压与有创动脉血压虽总体强相关,但临床相关差异频繁,两者不可互换。

本研究为前瞻性观察性研究,纳入70例在神经重症监护病房接受持续血管升压药或降压药输注的患者,共收集2177对同步无创血压(NBP)与有创动脉血压(IAP)记录。配对t检验显示NBP与IAP存在显著差异:收缩压均值136 vs 140 mmHg(p<0.0001),舒张压70 vs 68 mmHg(p<0.0001),平均动脉压86 vs 90 mmHg(p<0.0001)。Bland-Altman分析显示配对测量间总体一致性良好(排除离群值),但在血压极端值处NBP-IAP收缩压差异明显。Pearson相关系数显示配对MAP(r=0.82)、SBP(r=0.84)、DBP(r=0.73)呈强正相关。作者结论认为,尽管总体强相关,但临床相关血压差异频繁,NBP与IAP值不可互换。

要点

  • 在接受尼卡地平、去甲肾上腺素或去氧肾上腺素输注的患者中,NBP-IAP收缩压绝对差>20 mmHg分别见于约20%、约25%和约35%的观测。
  • MAP的NBP-IAP绝对差>20 mmHg分别见于尼卡地平约10%、去甲肾上腺素约15%、去氧肾上腺素约25%的观测。
  • 配对t检验显示NBP与IAP显著不同:SBP均值136 vs 140 mmHg,DBP均值70 vs 68 mmHg,MAP均值86 vs 90 mmHg(均p<0.0001)。
  • 配对MAP(r=0.82)、SBP(r=0.84)、DBP(r=0.73)呈强正相关,Bland-Altman分析示总体一致性良好(排除离群值)。
  • 作者强调,当以特定血压目标进行血管活性药物输注治疗时,NBP与IAP值不可互换。

适用人群与场景

  • 纳入连续接受血管升压药或降压药输注的神经重症监护病房患者(N=70;49%男性,63%白人,平均年龄59岁;血管升压药n=21,降压药n=49)。

研究设计与关键结果

  • 前瞻性观察性研究,纳入70例神经重症监护病房接受持续血管升压药或降压药输注的患者,共收集2177对同步NBP/IAP观测。
  • 配对t检验显示NBP与IAP显著不同:SBP均值136 vs 140 mmHg(p<0.0001),DBP均值70 vs 68 mmHg(p<0.0001),MAP均值86 vs 90 mmHg(p<0.0001)。
  • Bland-Altman分析显示配对MAP、SBP、DBP总体一致性良好(排除离群值),并在血压极端值处显示NBP-IAP收缩压差异。
  • Pearson相关系数显示配对MAP(r=0.82)、SBP(r=0.84)、DBP(r=0.73)呈强正相关。
  • NBP-IAP收缩压绝对差>20 mmHg见于约20%的尼卡地平观测、约25%的去甲肾上腺素观测、约35%的去氧肾上腺素观测;MAP的相应比例分别约为10%、15%、25%。

证据类型、等级与局限

  • 证据类型:前瞻性观察性研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,当以特定血压目标进行血管活性药物输注治疗时,需牢记NBP与IAP值不可互换。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: The correlation between noninvasive (oscillometric) blood pressure (NBP) and intra-arterial blood pressure (IAP) in critically ill patients receiving vasoactive medications in a Neurocritical Care Unit has not been systematically studied. The purpose of this study is to examine the relationship between simultaneously measured NBP and IAP recordings in these patients.

METHODS: Prospective observational study of patients (N = 70) admitted to a neurocritical care unit receiving continuous vasopressor or antihypertensive infusions. Paired NBP/IAP observations along with covariate and demographic data were abstracted via chart audit. Analysis was performed using SAS v9.4.

RESULTS: A total of 2177 paired NBP/IAP observations from 70 subjects (49% male, 63% white, mean age 59 years) receiving vasopressors (n = 21) or antihypertensive agents (n = 49) were collected. Paired t test analysis showed significant differences between NBP versus IAP readings: ([systolic blood pressure (SBP): mean = 136 vs. 140 mmHg; p < 0.0001], [diastolic blood pressure (DBP): mean = 70 vs. 68 mmHg, p < 0.0001], [mean arterial blood pressure (MAP): mean = 86 vs. 90 mmHg, p < 0.0001]). Bland-Altman plots for MAP, SBP, and DBP demonstrate good inter-method agreement between paired measures (excluding outliers) and demonstrate NBP-IAP SBP differences at extremes of blood pressures. Pearson correlation coefficients show strong positive correlations for paired MAP (r = 0.82), SBP (r = 0.84), and DBP (r = 0.73) recordings. An absolute NBP-IAP SBP difference of > 20 mmHg was seen in ~ 20% of observations of nicardipine, ~ 25% of observations of norepinephrine, and ~ 35% of observations of phenylephrine. For MAP, the corresponding numbers were ~ 10, 15, and 25% for nicardipine, norepinephrine, and phenylephrine, respectively.

CONCLUSION: Despite overall strong positive correlations between paired NBP and IAP readings of MAP and SBP, clinically relevant differences in blood pressure are frequent. When treating with vasoactive infusions targeted to a specific BP goal, it is important to keep in mind that NBP and IAP values are not interchangeable.

来源:Neurocrit Care,查看原文。版权归原作者所有。

参考来源

  1. Saherwala AA, Stutzman SE, Osman M, et al. Correlation of Noninvasive Blood Pressure and Invasive Intra-arterial Blood Pressure in Patients Treated with Vasoactive Medications in a Neurocritical Care Unit. Neurocrit Care. 2018. PMID: 29569130. doi:10.1007/s12028-018-0521-0

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。